BRBruker BRKR · NASDAQ
$55.37 +1.04% (+$0.57)
- Market cap
- $8.44B
- Enterprise value
- $10.2B
- P/E
- -
- Forward P/E
- 25.9x
- PEG
- -
- P/S
- 2.4x
- P/FCF
- 89.8x
- EV/EBITDA
- 41.0x
- ROIC
- 6.3%
- Gross margin
- 46.7%
- Net margin
- -2.0%
- Dividend yield
- 0.36%
- Payout ratio
- -
- Net debt/EBITDA
- 7.0x
- Beta
- 1.22
- Free float
- 68.1%
About the company
Bruker Corporation (BRKR) is a leading global provider of scientific and analytical instruments for research and diagnostics. The company develops and manufactures devices and technologies for various industries, including biomedicine, pharmaceuticals, materials science, and more. It is known for its innovative approaches and products that enable researchers and experts to gain deeper insights into materials and biological systems. With its research efforts, diverse portfolio, and extensive experience, investing in Bruker Corporation (BRKR) shares may present an interesting investment opportunity for investors interested in the scientific and analytical sector.
Sector
Healthcare
Industry
Medical - Devices
CEO
Frank H. Laukien
Employees
11,085
Headquarters
Billerica
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number